1. India Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: other
TMT (India) Ltd

TMT (India) Ltd

BBSE:TMTIND_B1
8.87
INR
0.00
(0.00%)
-0.05EPS
39.19MMarket Cap
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
0.11
0.16
0.66
0.62
0.67
0.31
- -
0.86
- -
0.08
- -
0.09
0.09
Basic EPS, GAAP
-0.82
-0.16
-0.14
-0.71
-1.43
-7.42
- -
-2.32
-3.42
-0.69
-0.93
-0.18
-0.05
Free Cash Flow per Basic Share
-0.1
-0.1
-0.38
-0.56
-6.28
-0.41
- -
-0.9
-0.88
-0.76
-0.6
-0.39
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
1.96
1.86
3.56
2.74
1.01
-6.29
- -
-8.07
-11.31
-12.17
-12.96
-13.3
- -
Tangible Book Value per Share
1.96
1.86
3.56
2.74
1.01
-6.29
- -
-8.07
-11.31
-12.17
-12.96
-13.3
- -
Basic Weighted Avg Shares
5
5
5
5
5
5
5
5
5
5
5
5
5
Sales/Revenue/Turnover
1
1
3
3
3
2
- -
4
- -
- -
- -
- -
- -
Operating Margin (%)
-176.09
-103.3
-32.44
-121.48
-214.85
-2,403.2
- -
-84.86
- -
-838.55
- -
-484.6
-359.15
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-4
-1
-1
-4
-7
-37
- -
-12
-17
-3
-5
-1
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-769.94
-99.82
-21.02
-116.06
-215.17
-2,403.79
- -
-271.58
- -
-892.35
- -
-192.09
-52.13
Working Capital
30
29
37
33
53
22
- -
14
- -
- -
-1
1
- -
LT Debt
24
24
24
24
51
55
- -
58
62
65
68
70
- -
Total Equity
10
9
18
14
5
-31
- -
-40
-56
-60
-64
-66
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
-8.51
-5.11
-22.67
-76.38
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
- -
- -
LT Borrowings
- -
70
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
5
5
5
Market Capitalization
32
36
39

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
2
- -
Cash, Cash Equivalents & STI
- -
1
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
1
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
2.63%
Free Cash Flow
- -
- -
-34.74%
Net Income, GAAP
-3,093,957.99%
-6,188,079.87%
-80.36%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-0.15
-0.15
-0.14
-0.49
-0.93
2026
-0.16
- -
-0.08
0.13
-0.18
2027
-0.1
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Mitesh Kothari
Full Time Employees
7
Sector
Health technology
Industry
Pharmaceuticals: other
Address
25-8-113 Hyderabad AP India 500001
IPO Date
Mar 12, 1999
Website
tmtindia.in
Similar Companies
Cipla Ltd (NSE:CIPLA)
Aurobindo Pharma Ltd (NSE:AUROPHARMA)
Lupin Limited (NSE:LUPIN)
Granules India Limited (NSE:GRANULES)
Revolution Medicines, Inc. (NASDAQ:RVMD)
Egyptian International Pharmaceutical Industries Co. (EGX:PHAR)
Business
TMT (India) Ltd. operates as a producer of natural herbs and extracts, offering an extensive product range including curcumin, boswellic acid, garcinia double salt, garcinia single salt, ashwagandha, bacopa, tribulus terrestris dry, green tea extract, coleus, ginger oleoresin, pepper extract, and coffee extract. The company’s core business activities encompass the manufacture and sale of these herbal extracts primarily targeting industries such as pharmaceuticals, nutraceuticals, and cosmetics. Founded in 1976 and headquartered in Hyderabad, India, TMT (India) Ltd. has a longstanding presence in the agro-based products sector with additional involvement in civil construction works. Recently, TMT (India) Ltd. has focused on expanding its renewable energy and biodegradable product initiatives, notably entering into agreements to supply eco-friendly products to healthcare and hospitality sectors such as Apollo Hospitals, MGM Hospital Canteens, and GRT Group of Hotels. The company has also developed capabilities in waste management systems and renewable energy projects, including a commissioned 6 MW solar project in Southern Tamil Nadu and bio-gas power set-ups in collaboration with international partners in Australia and the Maldives. These strategic expansions into green energy and sustainable product lines mark significant operational shifts within the last two years. TMT (India) Ltd. operates across India, emphasizing the natural products market and environmental sustainability solutions. Its strategic partnerships and agreements in the health and hospitality sectors reflect its diversification and commitment to eco-friendly technologies. The company maintains its legacy from its former identity as Tungabhadra Machinery and Tools Limited and continues to deepen its footprint in herbal extracts production alongside new ventures in renewable energy and biodegradables, underscoring a broader commitment to sustainability and diversification within its industrial portfolio.